Marco Donia, Professor at University of Copenhagen, shared a post on LinkedIn:
“Joining ESMO 2025? Do not miss the exciting session on Treatment approaches for checkpoint inhibitor–resistant tumors
Featuring a phenomenal team of established and rising stars of Immuno-Oncology such as:
- Drew Pardoll: Mechanisms of primary and acquired resistance to CPI
- Margaret Ottaviano: Combination of CPI + CPI and other classical agents
- Thomas Gajewski: Intratumoral immunotherapies and vaccines
My privilege to close this session with a talk about Cellular therapies and T cell engagers
If you have not registered yet, you still have time to do so here.
Full Programme at of ESMO Immuno Oncology Congress 2025 ((London, 10-12 Dec 2025).”
More posts featuring Marco Donia.